Home300142 • SHE
add
Walvax Biotechnology Co Ltd
Previous close
¥11.76
Year range
¥9.70 - ¥15.12
Market cap
19.03B CNY
Avg Volume
39.11M
P/E ratio
396.63
Dividend yield
-
Primary exchange
SHE
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 564.60M | -20.25% |
Operating expense | 404.88M | 13.73% |
Net income | 120.28M | 40.19% |
Net profit margin | 21.30 | 75.74% |
Earnings per share | — | — |
EBITDA | 158.64M | -52.94% |
Effective tax rate | 10.97% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.68B | -53.59% |
Total assets | 13.25B | -11.68% |
Total liabilities | 2.31B | -29.48% |
Total equity | 10.94B | — |
Shares outstanding | 1.60B | — |
Price to book | 1.94 | — |
Return on assets | 1.24% | — |
Return on capital | 1.51% | — |
Cash Flow
Net change in cash
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 120.28M | 40.19% |
Cash from operations | -36.96M | -107.88% |
Cash from investing | -54.04M | 60.11% |
Cash from financing | -765.49M | -2,157.09% |
Net change in cash | -856.82M | -392.33% |
Free cash flow | -1.43B | -2,758.22% |
About
Founded
Jan 16, 2001
Website
Employees
1,932
